The ever-growing antibiotic resistance to currently prescribed antibiotics constitutes a main reason for investigating natural compounds for antibacterial action. Natural products can be used as leads for new synthetic antibacterial agents or as a source of novel bioactive compounds. Cinnamaldehyde and colupulone were selected as lead compounds for the purposes of this study. Cinnamaldehyde, a byproduct of the stem bark of Cinnamomum cassia, was isolated in 1834 by Jean-Baptiste Dumas, with uses ranging from the food and cosmetics to pharmaceutical industries. Colupulone, is a known hop b-acid found in Humulus lupulus, a plant also used in the pharmaceutical and food industry. Previous studies have shown that both compounds exhibit antibacterial properties. In order to investigate essential structures responsible for enhanced action, some functionalities on the selected parental compounds, cinnamaldehyde and colupulone, were preserved while others altered. Synthesis of these analogues was based on short synthetic routes, including efficient methods like Wittig reaction, Fries rearrangement and C-alkylation of phloroglucinol derivatives. Subsequent testing for their antibacterial action against gram-positive and gram-negative microorganisms Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa revealed important functionalities required for increased activities. The prospective development of a ligand-based pharmacophore was also investigated, by analyzing the structural-activity relationship of their bacterial growth inhibitory potencies. Enhance inhibitory action was observed for the para-methoxy analogue of trans-cinnamaldehyde against E.coli. In addition, all tested colupulone analogues exhibited enhanced activities for both E. coli and S.aureus. These results set the base for designing new compounds to better understand structure-activity relationship and improve activity.